Volume 24, Issue 10
October 2022
Cover image
Cover image
Scheme from Figure 3 of the review by Cordell and Alghamri et al. “T lymphocytes as dynamic regulators of glioma pathobiology” beginning on p. 1647.
ISSN 1522-8517
EISSN 1523-5866
Issue navigation
Volume 24, Issue 10, October 2022
Reviews
Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1613–1646, https://doi.org/10.1093/neuonc/noac118
T lymphocytes as dynamic regulators of glioma pathobiology
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1647–1657, https://doi.org/10.1093/neuonc/noac055
Editorial
Understanding the relationship between gliomas and T cells: Paving the way for effective immunotherapy
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1658–1659, https://doi.org/10.1093/neuonc/noac152
Basic and Translational Investigations
Tumor-related molecular determinants of neurocognitive deficits in patients with diffuse glioma
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1660–1670, https://doi.org/10.1093/neuonc/noac036
Editorial
Molecularly determining cognition in glioma: New insights as the plot thickens
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1671–1672, https://doi.org/10.1093/neuonc/noac149
Basic and Translational Investigations
A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1673–1686, https://doi.org/10.1093/neuonc/noac054
Editorial
Preclinical modeling in leptomeningeal disease: Starting at the foundation to tackle a difficult disease
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1687–1688, https://doi.org/10.1093/neuonc/noac142
Basic and Translational Investigations
Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1689–1699, https://doi.org/10.1093/neuonc/noac088
STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1700–1711, https://doi.org/10.1093/neuonc/noac093
EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1712–1725, https://doi.org/10.1093/neuonc/noac105
Clinical Investigations
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1726–1735, https://doi.org/10.1093/neuonc/noac043
Editorial
Leptomeningeal metastases—What outcomes should we measure and how?
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1736–1737, https://doi.org/10.1093/neuonc/noac101
Clinical Investigations
Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1738–1748, https://doi.org/10.1093/neuonc/noac072
Prospective genomically guided identification of “early/evolving” and “undersampled” IDH-wildtype glioblastoma leads to improved clinical outcomes
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1749–1762, https://doi.org/10.1093/neuonc/noac089
Pediatric Neuro-Oncology
Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1763–1772, https://doi.org/10.1093/neuonc/noac035
Editorial
Liquid biopsy for pediatric brain tumor patients: is it prime time yet?
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1773–1775, https://doi.org/10.1093/neuonc/noac140
Pediatric Neuro-Oncology
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1776–1789, https://doi.org/10.1093/neuonc/noac087
Neuroimaging
Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1790–1798, https://doi.org/10.1093/neuonc/noac100
Epidemiology
Adult brain tumors in Sub-Saharan Africa: A scoping review
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1799–1806, https://doi.org/10.1093/neuonc/noac098
Letter to the Editor
Prevalence of autoimmunity and atopy in US adults with glioblastoma and meningioma
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1807–1809, https://doi.org/10.1093/neuonc/noac145
Society News
Forthcoming Meetings
Neuro-Oncology, Volume 24, Issue 10, October 2022, Page 1810, https://doi.org/10.1093/neuonc/noac222
